KALBE FARMAKALBE FARMAKALBE FARMA

KALBE FARMA

No trades
See on Supercharts
Market capitalization
‪67.97 T‬IDR
‪2.77 T‬IDR
‪30.45 T‬IDR
‪18.72 B‬
Beta (1Y)
0.28

About KALBE FARMA

CEO
Vidjongtius
Headquarters
Jakarta
Employees (FY)
‪13.11 K‬
Founded
1966
ISIN
ID1000125107
FIGI
BBG000BFRVS5
PT Kalbe Farma Tbk is engaged in the development, distribution, and trading of pharmaceutical products. It operates through the following divisions: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical division offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores. The Consumer Health division includes over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals division sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution and Logistic division maintains distribution of the company's and third party principal's products across Indonesia; and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of KLBF is 1420.00 IDR — it has decreased by 2.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on IDX exchange KALBE FARMA stocks are traded under the ticker KLBF.
KALBE FARMA is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for KALBE FARMA has a max estimate of 1850.00 IDR and a min estimate of 1530.00 IDR.
KLBF earnings for the last quarter are 11.23 IDR whereas the estimation was 17.57 IDR which accounts for −36.08% surprise. Estimated earnings for the next quarter are 15.81 IDR. See more details about KALBE FARMA earnings.
KALBE FARMA revenue for the last quarter amounts to ‪7.38 T‬ IDR despite the estimated figure of ‪7.75 T‬ IDR. In the next quarter revenue is expected to reach ‪7.86 T‬ IDR.
Yes, you can track KALBE FARMA financials in yearly and quarterly reports right on TradingView.
KLBF stock has fallen by 5.33% compared to the previous week, the last month showed zero change in price, over the last year KALBE FARMA has showed a 30.05% decrease.
Like other stocks, KLBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KALBE FARMA stock right from TradingView charts — choose your broker and connect to your account.
KLBF reached its all-time high on Feb 13, 2023 with the price of 2360.00 IDR, and its all-time low was 71.00 IDR and was reached on Oct 28, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪13.11 K‬ employees. See our rating of the largest employees — is KALBE FARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KALBE FARMA EBITDA is ‪4.32 T‬ IDR, and current EBITDA margin is 14.20%. See more stats in KALBE FARMA financial statements.